🎉 We’re proud to share that Protyon has been selected as a recipient of the Women TechEU award! 🥇 🚀
This EU-funded program supports female entrepreneurs leading deep tech startups across Europe and Associated Countries. We’re especially proud of our CEO, Rositsa Jordanova, whose leadership exemplifies the strength and innovation women bring to the tech and healthcare sectors.
At Protyon, we are developing a software solution that leverages advanced 3D molecular modeling to support personalized cancer therapy. Our goal is to improve targeted treatment decisions, enhance therapeutic outcomes, and ultimately extend the lives of patients with cancer.
A heartfelt thank you to our team, partners, and everyone who believes in our work. Together, we’re building the future of precision oncology
